Aerie Pharmaceuticals Logo

Investor Relations

We began with a vision, and now we’ve grown into an ophthalmic pharmaceutical company focused on discovering, developing, and commercializing first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases, and retinal diseases.

Leadership Team

Meet the eye care VISIONaerieS® building the next major ophthalmic pharmaceutical company.

MORE

Stock Information

REPORTS AND FILINGS

Review the latest annual report, quarterly reports, and other SEC filings.

MORE
TOP